S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ITCI Intra Cellular Therapies Inc

70.34

0.00 (0.00%)

Pre Market

Last Updated: 18:00:00

Delayed by 15 minutes

Intra-Cellular Therapies EPS beats by $0.09, beats on revenue

To read the full story on Seeking Alpha, click here.

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Intra Cellular Therapies Charts.

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Intra Cellular Therapies Charts.

Intra Cellular Therapies Inc News

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
Tuesday 30 April 2024 (3 days ago) • GlobeNewswire Inc.

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Intra-Cellular Therapies Prices Public Offering of Common Stock
Thursday 18 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

More Intra Cellular Therapies Inc News Articles

Invesco QQQ Trust Series 1

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions